Isac C Thomas1, Matthew A Allison2. 1. Department of Medicine, Division of Cardiovascular Medicine, University of California San Diego, 9452 Medical Center Dr., La Jolla, CA, 92037-7411, USA. icthomas@ucsd.edu. 2. Department of Family Medicine and Public Health, Division of Preventive Medicine, University of California San Diego, La Jolla, CA, USA.
Abstract
ABSTRAC: PURPOSE OF REVIEW: Hispanic/Latino Americans are among the fastest growing ethnic populations in the United States (US). Hypertension, in particular uncontrolled hypertension, is a significant source of cardiovascular morbidity and mortality in this population. In this review, we outline the epidemiology of hypertension and certain considerations in the management of hypertension in this heterogeneous population. RECENT FINDINGS: Substantial variation in hypertension prevalence and control exists among different ethnic subgroups of Hispanics. More specifically, and in the community, outcomes for hypertension management are less favorable, suggesting that suboptimal hypertension control may be the result of social factors. In this regard, community-based interventions have shown promise in addressing these shortfalls. Nonetheless, significant barriers to effective hypertension care exist in the Hispanic community, including the increasing prevalence of comorbidities that impact hypertension such as obesity. Pharmacologic therapies for hypertension have been highly effective in Hispanic subjects participating in clinical trials. Notably, studies that disaggregate Hispanics by their ancestral origin may provide greater insight into the sources of ethnic disparities. Culturally tailored interventions may improve hypertension management and outcomes in Hispanic populations. Additional population and clinical trials in Hispanic patients of different ancestral heritages are needed.
ABSTRAC: PURPOSE OF REVIEW: Hispanic/Latino Americans are among the fastest growing ethnic populations in the United States (US). Hypertension, in particular uncontrolled hypertension, is a significant source of cardiovascular morbidity and mortality in this population. In this review, we outline the epidemiology of hypertension and certain considerations in the management of hypertension in this heterogeneous population. RECENT FINDINGS: Substantial variation in hypertension prevalence and control exists among different ethnic subgroups of Hispanics. More specifically, and in the community, outcomes for hypertension management are less favorable, suggesting that suboptimal hypertension control may be the result of social factors. In this regard, community-based interventions have shown promise in addressing these shortfalls. Nonetheless, significant barriers to effective hypertension care exist in the Hispanic community, including the increasing prevalence of comorbidities that impact hypertension such as obesity. Pharmacologic therapies for hypertension have been highly effective in Hispanic subjects participating in clinical trials. Notably, studies that disaggregate Hispanics by their ancestral origin may provide greater insight into the sources of ethnic disparities. Culturally tailored interventions may improve hypertension management and outcomes in Hispanic populations. Additional population and clinical trials in Hispanic patients of different ancestral heritages are needed.
Authors: Jackson T Wright; J Kay Dunn; Jeffrey A Cutler; Barry R Davis; William C Cushman; Charles E Ford; L Julian Haywood; Frans H H Leenen; Karen L Margolis; Vasilios Papademetriou; Jeffrey L Probstfield; Paul K Whelton; Gabriel B Habib Journal: JAMA Date: 2005-04-06 Impact factor: 56.272
Authors: Rhonda M Cooper-DeHoff; Juan M Aranda; Efrain Gaxiola; Jose L Cangiano; David Garcia-Barreto; C Richard Conti; Ann Hewkin; Carl J Pepine Journal: Am Heart J Date: 2006-05 Impact factor: 4.749
Authors: Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He Journal: Lancet Date: 2005 Jan 15-21 Impact factor: 79.321
Authors: Andrew Moran; Ana V Diez Roux; Sharon A Jackson; Holly Kramer; Teri A Manolio; Sandi Shrager; Steven Shea Journal: Am J Hypertens Date: 2007-04 Impact factor: 2.689
Authors: Karen L Margolis; Linda B Piller; Charles E Ford; Mario A Henriquez; William C Cushman; Paula T Einhorn; Pedro J Colon; Donald G Vidt; Rudell Christian; Nathan D Wong; Jackson T Wright; David C Goff Journal: Hypertension Date: 2007-09-10 Impact factor: 10.190
Authors: Jesus D Melgarejo; Daniel C Aguirre-Acevedo; Ciro Gaona; Carlos A Chavez; Gustavo E Calmón; Eglé R Silva; Gabriel A de Erausquin; Mario Gil; Luis J Mena; Joseph D Terwilliger; Humberto Arboleda; Nikolaos Scarmeas; Joseph H Lee; Gladys E Maestre Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472